Correlation Between Xbrane Biopharma and Episurf Medical

Can any of the company-specific risk be diversified away by investing in both Xbrane Biopharma and Episurf Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xbrane Biopharma and Episurf Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Xbrane Biopharma AB and Episurf Medical AB, you can compare the effects of market volatilities on Xbrane Biopharma and Episurf Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xbrane Biopharma with a short position of Episurf Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xbrane Biopharma and Episurf Medical.

Diversification Opportunities for Xbrane Biopharma and Episurf Medical

0.19

Correlation Coefficient

Xbrane Biopharma  Episurf Medical

Average diversification

The 3 months correlation between Xbrane and Episurf is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Xbrane Biopharma AB and Episurf Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Episurf Medical AB and Xbrane Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xbrane Biopharma AB are associated (or correlated) with Episurf Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Episurf Medical AB has no effect on the direction of Xbrane Biopharma i.e., Xbrane Biopharma and Episurf Medical go up and down completely randomly.

Pair Corralation between Xbrane Biopharma and Episurf Medical

Assuming the 90 days trading horizon Xbrane Biopharma AB is expected to generate 1.0 times more return on investment than Episurf Medical. However, Xbrane Biopharma AB is 1.0 times less risky than Episurf Medical. It trades about -0.23 of its potential returns per unit of risk. Episurf Medical AB is currently generating about -0.24 per unit of risk. If you would invest  20.00  in Xbrane Biopharma AB on September 22, 2024 and sell it today you would lose (4.00) from holding Xbrane Biopharma AB or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

Xbrane Biopharma AB  vs.  Episurf Medical AB

Xbrane Biopharma

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Xbrane Biopharma AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Xbrane Biopharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Episurf Medical AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Episurf Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Xbrane Biopharma and Episurf Medical

The main advantage of trading using opposite Xbrane Biopharma and Episurf Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xbrane Biopharma position performs unexpectedly, Episurf Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Episurf Medical will offset losses from the drop in Episurf Medical's long position.

The idea behind Xbrane Biopharma AB and Episurf Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.